Cargando…

Clinical and Genetic Analysis in Neurological Wilson’s Disease Patients With Neurological Worsening Following Chelator Therapy

Objectives: None of the previous studies have focused on the genetic effect on neurological worsening in neurological Wilson’s disease (WD) patients following chelator therapy. We aimed to evaluate the clinical and genetic role in the occurrence of neurological worsening. Methods: We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Haiman, Chen, Dingbang, Liu, Junxiu, Feng, Li, Zhang, Jiwei, Liang, Xiuling, Xu, Yuming, Li, Xunhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013891/ https://www.ncbi.nlm.nih.gov/pubmed/35444691 http://dx.doi.org/10.3389/fgene.2022.875694

Ejemplares similares

Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D–Penicillamine Therapy: A Single Centre Experience
por: Kumar, Madhan, et al.
Publicado: (2022)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Neurological Phenotype of Mowat-Wilson Syndrome
por: Cordelli, Duccio Maria, et al.
Publicado: (2021)

Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson’s disease patients with penicillamine-induced allergy or early neurological deterioration
por: Zhu, Xiao-Qun, et al.
Publicado: (2020)

Evaluation of the Clinical, Biochemical, Neurological, and Genetic Presentations of Glutaric Aciduria Type 1 in Patients From China
por: E., Huishu, et al.
Publicado: (2021)

Characteristics of neurological Wilson’s disease with corpus callosum abnormalities
por: Zhou, Zhi-Hua, et al.
Publicado: (2019)

Predictors of caregiver burden in patients with neurologic Wilson disease
por: Wu, Peng, et al.
Publicado: (2020)

Early neurological worsening in acute ischaemic stroke patients
por: Nacu, A., et al.
Publicado: (2015)

Predictors of Neurological Worsening after Resection of Spinal Meningiomas
por: Jankovic, Dragan, et al.
Publicado: (2023)

Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

Neurological Wilson’s Disease Signs—Hepatic Encephalopathy or Copper Toxicosis?
por: Jopowicz, Anna, et al.
Publicado: (2023)

Long Non-coding RNA in Neuronal Development and Neurological Disorders
por: Li, Ling, et al.
Publicado: (2019)

An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma
por: Katrib, Amal, et al.
Publicado: (2019)

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

Combination Therapy Using Chelating Agent and Zinc for Wilson’s Disease
por: Chen, Jui-Chi, et al.
Publicado: (2015)

The Effect of Chelation Therapy on the Amino Aciduria and Peptiduria of Wilson's Disease
por: Asatoor, A. M., et al.
Publicado: (1983)

Hypopituitarism in Wilson’s disease resolved after copper-chelating therapy
por: Dauth, Nina, et al.
Publicado: (2021)

Neurologic Wilson disease: case series on a diagnostic and therapeutic emergency
por: Porlas Jr, Romeo V., et al.
Publicado: (2018)

Brain volume is related to neurological impairment and to copper overload in Wilson’s disease
por: Smolinski, Lukasz, et al.
Publicado: (2019)

Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease
por: Shribman, Samuel, et al.
Publicado: (2020)

Linear structural features of Wilson’s disease and its correlation with neurological symptoms
por: Diao, Sheng-Peng, et al.
Publicado: (2022)

Neurological-Type Wilson Disease: Epidemiology, Clinical Manifestations, Diagnosis, and Management
por: Kipker, Nathaniel, et al.
Publicado: (2023)

Advances in non-coding RNA profiling for neurological diseases
por: Cairns, Murray J., et al.
Publicado: (2013)

Molecular mechanisms of long ncRNAs in neurological disorders
por: Vučićević, Dubravka, et al.
Publicado: (2014)

The Molecular Function of PURA and Its Implications in Neurological Diseases
por: Molitor, Lena, et al.
Publicado: (2021)

Loop Interrupted: Dysfunctional Chromatin Relations in Neurological Diseases
por: Behrends, Marthe, et al.
Publicado: (2021)

Clinical and genetic characterization of pediatric patients with Wilson’s disease from Yunnan province where ethnic minorities gather
por: Wang, Yanjun, et al.
Publicado: (2023)

Neurological worsening during treatment of an immunocompetent adult with Cryptococcus neoformans meningitis
por: Tanu, Singhal, et al.
Publicado: (2020)

Can COVID-19 pandemic worsen previous neurological/psychiatric diseases?
por: Fleury, A., et al.
Publicado: (2022)

THE PSYCHIATRIC ASPECTS OF WILSON'S DISEASE-A STUDY FROM A NEUROLOGY UNIT
por: Kumar, Rajeev, et al.
Publicado: (1996)

Type 2 diabetes mellitus worsens neurological injury following cardiac arrest: an animal experimental study
por: Vammen, Lauge, et al.
Publicado: (2018)

Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders
por: Niland, Courtney N., et al.
Publicado: (2012)

Neurologic Features with Pathogenic Copy Number Variants
por: Coryell, Jason
Publicado: (2020)

A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
por: George, Arlene J., et al.
Publicado: (2018)

Idiopathic Thrombocytopenia and Neurologic Manifestations in A Young Female Leading to the Diagnosis of Wilson’s Disease
por: Zaheryany, Seyed Mohammad Salar, et al.
Publicado: (2012)

Clinical significance of self-descriptive apathy assessment in patients with neurological form of Wilson’s disease
por: Leśniak, Marcin, et al.
Publicado: (2021)

Psychiatric Symptoms sans Hepato-Neurological symptoms in Wilson Disease – A case Report
Publicado: (2022)

Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson’s disease at diagnosis
por: Diao, Sheng-Peng, et al.
Publicado: (2023)

Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023)

Predictors of Early Neurological Deterioration Following Intravenous Thrombolysis: Difference between Risk Factors for Ischemic and Hemorrhagic Worsening
por: Nair, Srikumar B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gbkmrjk6b9i9vb4p9j7f2thc2q